CDC reports fewer COVID-19 pediatric deaths after data correction

The U.S. Centers for Disease Control and Prevention reported 966,575 deaths from COVID-19 on Friday after it corrected the data earlier this week, which reduced the death tallies in all age-groups, including children.

The health agency, in a statement to Reuters, said it made adjustments to its COVID Data Tracker’s mortality data on March 14 because its algorithm was accidentally counting deaths that were not COVID-19-related.

The adjustment resulted in removal of 72,277 deaths previously reported across 26 states, including 416 pediatric deaths, CDC said.

The reduction cut the CDC’s estimate of deaths in children by 24% to 1,341 as of March 18.
— Read on news.yahoo.com/cdc-reports-fewer-covid-19-204027980.html

Kakistocracy: noun, government by the worst persons; a form of government in which the worst persons are in power

Kakistocracy: noun, government by the worst persons; a form of government in which the worst persons are in power.

The old saying goes that even a blind squirrel finds a nut occasionally.  So you might think that during a 50-year political career, the odds would dictate that Joe Biden would, once in a blue moon, make a correct decision — just based on the odds.  But you’d be mistaken.  Biden has stumbled and bumbled from one disastrous decision to the next.  Disastrous, that is, for America.  Biden himself has prospered handsomely in spite of his glaring incompetence and corruption. 

Biden’s long Senate career was based on being the credit card companies’ man in Washington.  While crowing endlessly about the working class being “his people,” Biden sponsored bills allowing bank issuers to charge egregious interest rates and to make it harder for working men to escape the credit trap through bankruptcy.

When Biden chaired the Senate Judiciary Committee, he turned the confirmation of Clarence Thomas into a political smear campaign that descended into a degenerate three-ring circus. In his first campaign for president, he failed to garner a single percentage point before having to withdraw when confronted with his past lies and blatant plagiarism. He literally stole a speech detailing a British politician’s life story. He ran again in 2008 but again failed to reach even one percent of the vote.

When Barack Obama took him off the primary trash heap to make him vice president, Biden first made a hash out of the 2009 American Recovery and Reinvestment Act, wasting hundreds of billions on boondoggles and giveaways to Democrat cronies. Little of the recovery billions was spent on anything useful to America. Biden went on to manage our relations with China and Ukraine, pocketing untold millions for himself and his family by selling out America’s security interests.

By the time he ran for president again in 2020 he was a spent husk of his former corrupt and incompetent self, delivering asinine performances in the Iowa caucus and New Hampshire primary. When the Democrat establishment propped him up to once again stop Bernie Sanders, Biden was set up for the strangest presidential campaign in modern history. While Donald Trump barnstormed the nation with packed, enthusiastic rallies, Biden cowered in his basement, occasionally venturing out to speak with a few dozen voters sitting in circles drawn on the floor.

For his vice presidential pick, he chose — if you can believe it — an even more buffoonish candidate than himself.

Had it not been for Mark Zuckerberg buying and staffing government election offices in swing states, and the media and Big Tech’s censorship of the Biden family’s corruption, Biden would now be enjoying his dotage in Delaware, creeping on unsuspecting children with yarns of Corn Pop and South African arrests.

Instead, the man with one of the most astonishing records of abject failure in Washington was installed in the White House, and he has remained true to form.  As one of a hundred senators and then as vice president, there was a limit to how much damage he could do.  But as president, the shackles have been removed.

His first agenda item was to throttle our oil and gas sector, offshoring tens of thousands of good paying jobs to Russia and the Middle East — along with our energy independence. He threw open our southern border and encouraged virtually unlimited illegal immigration — during a global pandemic.

He sponsored trillions of dollars in wasteful spending, pushing our national debt to over $31 trillion.  Were it not for two Democrat senators who had not yet taken leave of their senses, it would have been even worse.  As it is, Biden has sparked the largest one-year increase in inflation in 40 years.

Biden’s “defund the police” rhetoric delivered us soaring violent crime in Democrat-run cities, while he sicced federal law enforcement on parents who object too strenuously to their children being indoctrinated with anti-White racism and LGBTQIA+ ideology. 

It can truly be said that as president, Biden’s record of failure remains unblemished.  

But now comes what may be the capstone on Biden’s long history of buffoonery and corruption.  In Ukraine, we have an armed conflict that threatens to plunge the world into an economic depression and raises the specter of nuclear war.  Not only did Biden set the stage for this calamity when, as vice president, he was in charge of Ukraine policy and led Kiev to believe that NATO membership was in Ukraine’s future, but on the eve of the Russian invasion, he refused to admit that it was not.  Then Biden all but admitted to Vladimir Putin — on live TV, no less — that NATO would not defend Ukraine if Russia chose to invade. 

In the aftermath of Russia’s invasion, Biden and his administration have crafted sanctions that seem almost designed to boomerang on America’s and Europe’s fragile post-pandemic economies, while forcing Russia into a deeper alliance with China

With the U.S. over $31 trillion in debt, Biden seems totally oblivious to the perilous position of the U.S. dollar as the world’s reserve currency and the consequences should that privileged position end. 

Economists predict that food and gasoline will cost the average U.S. household an additional $3,000 this year, and inflation threatens to push millions of lower-middle income-earners into abject poverty.

And bumbling, corrupt Joe Biden isn’t yet halfway through his first — and please God, last — term.

Image: Gage Skidmore via Flickr, CC BY-SA 2.0.
Image: Gage Skidmore via Flickr, CC BY-SA 2.0.

Image: Gage Skidmore via Flickr, CC BY-SA 2.0.

Jim Daws is a recovering talk radio host at jimdaws.com.

Big Tech Censored Dozens of Doctors, More Than 800 Accounts for COVID-19 ‘Misinformation,’ Study Finds

Resource : https://www.bloomberg.com/press-releases/2022-02-08/merck-and-ridgeback-announce-that-3-1-million-courses-of-molnupiravir-an-investigational-oral-antiviral-covid-19-medicine-have

Big Tech Censored Dozens of Doctors, More Than 800 Accounts for COVID-19 ‘Misinformation,’ Study Finds

Ailan Evans / @AilanHEvans / February 09, 2022

Twitter, Google, Google+, Gmail, Facebook, Instagram, and Snapchat are among the platforms arrayed on the screen of an Apple iPhone. Many of them have used their largely unregulated power to censor information they don’t approve of as “misinformation.” (Photo: Chesnot/Getty Images)

Major technology companies and social media platforms have removed, suppressed or flagged the accounts of more than 800 prominent individuals and organizations, including medical doctors, for COVID-19 “misinformation,” according to a new study from the Media Research Center.

The study focused on acts of censorship on major social media platforms and online services, including Facebook, YouTube, Instagram, Twitter, LinkedIn, Google Ads, and TikTok.

dailycallerlogo

Instances of censorship included Facebook’s decision to flag the British Medical Journal with a “fact check” and “missing context” label, reducing the visibility of a post, for a study delving into data-integrity issues with a Pfizer vaccine clinical trial.

Facebook also deleted the page of the Great Barrington Declaration, an open letter led by dozens of medical professionals, including Dr. Jay Battacharya, a Stanford epidemiologist, and Dr. Martin Kulldorff, a former employee of the Centers for Disease Control and Prevention, which advocated for less restrictive measures to address the dangers of COVID-19.

“Big Tech set up a system where you can’t disagree with ‘the science’ even though that’s the foundation of the scientific method,” Dan Gainor, MRC vice president of Free Speech America, told the Daily Caller National Foundation. “If doctors and academic journals can’t debate publicly, then it’s not science at all. It’s ‘religion.’”

Big Tech also scrubbed podcast host Joe Rogan’s interviews with scientists Dr. Peter McCullough and Dr. Robert Malone, the latter of whom was instrumental in pioneering mRNA technology. Twitter banned Malone from its platform permanently in late December over the virologist’s tweets questioning the efficacy and safety of the COVID-19 vaccine.

“We tallied 32 different doctors who were censored, including mRNA vaccine innovator Dr. Robert Malone,” Gainor said. “Censoring views of credentialed experts doesn’t ensure confidence in vaccines. It undermines faith in government COVID-19 strategies.“

In addition to medical doctors, the study examined instances in which members of Congress were censored by tech platforms.

These included an incident last August in which YouTube suspended Sen. Rand Paul, R-Ky., for posting a video arguing that “cloth masks” are not effective against the coronavirus, a view later echoed by many prominent medical commentators. Twitter also flagged a tweet from Rep. Thomas Massie, R-Ky., in which he wrote “studies show those with natural immunity from a prior infection are much less likely to contract and spread COVID than those who only have vaccine-induced immunity.”

The study also examined Big Tech censorship of prominent media personalities, such as Rogan, Tucker Carlson, and Dan Bongino.

Content created by The Daily Caller News Foundation is available without charge to any eligible news publisher that can provide a large audience. For licensing opportunities of this original content, contact licensing@dailycallernewsfoundation.org.

Have an opinion about this article? To sound off, please email letters@DailySignal.com and we’ll consider publishing your edited remarks in our regular “We Hear You” feature. Remember to include the url or headline of the article plus your name and town and/or state.

Want to keep up with the 24/7 news cycle? Want to know the most important stories of the day for conservatives? Need news you can trust? Subscribe to The Daily Signal’s email newsletter. Learn more >>

NIH Quietly Edits Section of Website on Gain-of-Function Research

NIH Quietly Edits Section of Website on Gain-of-Function Research

NIH Quietly Edits Section of Website on Gain-of-Function Research

The National Institutes of Health edited a section of its website explaining gain-of-function research this month as scrutiny over the research the NIH funded in Wuhan, China intensified.

The original page, seen on the Wayback Machine, displays several sections including Potential Pandemic Pathogens, Gain-of-Function Research, U.S. Government Funding Pause, HHS P3CO Framework, Research Within P3CO Scope, Research Outside P3CO Scope, and a Timeline.

The Gain-of-Function section stated:

The term gain-of-function (GOF) research describes a type of research that modifies a biological agent so that it confers new or enhanced activity to that agent. Some scientists use the term broadly to refer to any such modification. However, not all research described as GOF entails the same level of risk. For example, research that involves the modification of bacteria to allow production of human insulin, or the altering of the genetic program of immune cells in CAR-T cell therapy to treat cancer generally would be considered low risk. The subset of GOF research that is anticipated to enhance the transmissibility and/or virulence of potential pandemic pathogens, which are likely to make them more dangerous to humans, has been the subject of substantial scrutiny and deliberation. Such GOF approaches can sometimes be justified in laboratories with appropriate biosafety and biosecurity controls to help us understand the fundamental nature of human-pathogen interactions, assess the pandemic potential of emerging infectious agents, and inform public health and preparedness efforts, including surveillance and the development of vaccines and medical countermeasures. This research poses biosafety and biosecurity risks, and these risks must be carefully managed. When supported with NIH funds, this subset of GOF research may only be conducted in laboratories with stringent oversight and appropriate biosafety and biosecurity controls(link is external) to help protect researchers from infection and prevent the release of microorganisms into the environment. (NIH)

Now the page lists only Potential Pandemic Pathogens, ePPP Research, and Oversight.

The edits come as Sen. Rand Paul is calling for Dr. Anthony Fauci to resign for lying about gain-of-function research.

“He should be fired,” Paul told “Axios on HBO” in an interview that aired Sunday. 

“The thing is, is just for lack of judgment of nothing else, and I, you know, he’s probably never going to admit that he lied, he’s going to continue to dissemble and try to work around the truth and massage the truth,” he added.

While Paul has been making this case for awhile, the sentiments were renewed after Lawrence Tabak, the principal deputy director at the NIH, revealed new details in a letter about an NIH grant to EcoHealth Alliance, which conducted research at the Wuhan Institute of Virology.

NOTICE – Regulations.govVaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for CommentsPosted by the Food and Drug Administration on Oct 12, 2021

Action

Notice; establishment of a public docket; request for comments.

Summary

The Food and Drug Administration (FDA or Agency) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. Members will participate via teleconference. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

Dates

The meeting will be held on October 26, 2021, from 8:30 a.m. to 5 p.m. Eastern Time. Submit either electronic or written comments on this public meeting by October 25, 2021. Comments received on or before October 21, 2021, will be provided to the committee. Comments received after October 21, 2021, and by October 25, 2021, will be taken into consideration by FDA.

Addresses

Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform. The online web conference meeting will be available at the following link on the day of the meeting: https://youtu.be/laaL0_xKmmA.

FDA is establishing a docket for public comment on this meeting. The docket number is FDA-2021-N-1088. The docket will close on October 25, 2021. Please note that late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of October 25, 2021. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are received on or before that date.

In the event that the meeting is cancelled, FDA will continue to evaluate any relevant applications, submissions, or information, and consider any comments submitted to the docket, as appropriate. 

You may submit comments as follows:

Electronic Submissions

Submit electronic comments in the following way:

• Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov.

  • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see “Written/Paper Submissions” and “Instructions”).

Written/Paper Submissions

Submit written/paper submissions as follows:

• Mail/Hand delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

  • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in “Instructions.”

Instructions: All submissions received must include the Docket No. FDA-2021-N-1088 for “Vaccines and Related Biological Products; Notice of Meeting; Establishment of a Public Docket; Request for Comments.” Received comments, those filed in a timely manner (see ADDRESSES ), will be placed in the docket and, except for those submitted as “Confidential Submissions,” publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240-402-7500.

• Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states “THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.” FDA will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify the information as “confidential.” Any information marked as “confidential” will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.

Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the “Search” box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852, 240-402-7500.

For Further Information Contact

Prabhakara Atreya or Kathleen Hayes, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 6307C, Silver Spring, MD 20993-0002, 301-796-7864; via email at CBERVRBPAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency’s website at https://www.fda.gov/AdvisoryCommittees/default.htmand scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.

Supplementary Information

Consistent with FDA’s regulations, this notice is being published with less than 15 days prior to the date of the meeting based on a determination that convening a meeting of the VRBPAC as soon as possible is warranted. This Federal Register notice could not be published 15 days prior to the date of the meeting due to a recent request to amend the Pfizer-BioNTech’s Emergency Use Authorization (EUA) for administration of their COVID-19 mRNA vaccine to children 5 through 11 years of age and the need for prompt discussion of this request given the COVID-19 pandemic.

Agenda: The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On October 26, 2021, the committee will meet in open session to discuss a request to amend Pfizer-BioNTech’s EUA for administration of their COVID-19 mRNA vaccine to children 5 through 11 years of age.

FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting, background material will be made publicly available on FDA’s website at the time of the advisory committee meeting. Background material and the link to the online teleconference meeting room will be available at https://www.fda.gov/advisory-committees/advisory-committee-calendar. Scroll down to the appropriate advisory committee meeting link. The meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting.

Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. All electronic and written submissions submitted to the Docket (see ADDRESSES) on or before October 21, 2021, will be provided to the committee. Comments received after October 21, 2021, and by October 25, 2021, will be taken into consideration by FDA. Oral presentations from the public will be scheduled between approximately 12:45 p.m. and 1:45 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before October 19, 2021. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 20, 2021.

For press inquiries, please contact the Office of Media Affairs at fdaoma@fda.hhs.gov or 301-796-4540.

FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact Prabhakara Atreya or Kathleen Hayes ( CBERVRBPAC@fda.hhs.gov) at least 7 days in advance of the meeting.

FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our website at: https://www.fda.gov/advisory-committees/about-advisory-committees/public-conduct-during-fda-advisory-committee-meetings for procedures on public conduct during advisory committee meetings.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).Dated: October 8, 2021.Lauren K. Roth,Associate Commissioner for Policy.[FR Doc. 2021-22452 Filed 10-8-21; 4:15 pm]BILLING CODE 4164-01-P

https://www.regulations.gov/document/FDA-2021-N-1088-0001